Piotr Ponikowski
Overview
Explore the profile of Piotr Ponikowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
870
Citations
52148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Docherty K, McDowell K, Welsh P, Petrie M, Anand I, Berg D, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088234
Background: Inflammation may play an important pathophysiological role in the development and progression of heart failure (HF). Interleukin (IL)-6 is a circulating cytokine and is the main regulator of the...
2.
Ghigo A, Ameri P, Asnani A, Bertero E, de Boer R, Farmakis D, et al.
Eur J Heart Fail
. 2025 Mar;
PMID: 40069106
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities...
3.
Inciardi R, Lu H, Claggett B, Desai A, Jhund P, Lam C, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40047763
Background: Patients with severe heart failure (HF) experience debilitating clinical symptoms and worse cardiovascular (CV) outcomes with an excess mortality risk. Objectives: The authors aimed to assess the prevalence, CV...
4.
Celutkiene J, Mebazaa A, Biegus J, Ponikowski P, Davison B, Cotter G
Card Fail Rev
. 2025 Feb;
11:e02.
PMID: 40018521
Diuretic therapy is not associated with improved outcomes in heart failure and may cause significant side effects. Counteracting the core pathophysiological mechanisms of heart failure through neurohormonal blockade while reducing...
5.
Skouri H, Girerd N, Monzo L, Petrie M, Bohm M, Adamo M, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 40012353
Despite major advancements in heart failure (HF) management and guideline recommendations over the past two decades, real-world evidence highlights suboptimal implementation of guideline-directed medical therapy (GDMT) for HF with reduced...
6.
Niewinski P, Tubek S, Josiak K, Nowak K, Ponikowski P
Sci Rep
. 2025 Feb;
15(1):6633.
PMID: 39994437
The autonomic regulation of heart rate (HR) reactivity to acute hypoxia remains unclear. Parasympathetic cardioneuroablation (PCNA) may serve as a novel model for the analysis of physiological consequences of reduced...
7.
Myhre P, Grupper A, Mebazaa A, Davison B, Edwards C, Takagi K, et al.
JACC Adv
. 2025 Feb;
4(3):101607.
PMID: 39983609
Background: Elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (tBil) may reflect congestion and liver dysfunction in acute heart failure (AHF), while lower ALT also associates with sarcopenia....
8.
Ferreira J, Vasques-Novoa F, Angermann C, Biegus J, Collins S, Kosiborod M, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39980254
Aims: Empagliflozin improves outcomes in acute heart failure (AHF). Patients with AHF and low blood pressure (BP) have poor prognosis. Whether empagliflozin is effective and safe in patients with AHF...
9.
Saldarriaga C, Zannad F, McMullan C, Xing A, Gates D, Anstrom K, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39956649
Aims: To describe the baseline characteristics of the participants in the VICTOR (Vericiguat Global Study in Patients with Chronic Heart Failure; NCT05093933) trial and compare them to recent trials in...
10.
Cotter G, Davison B, Mann D, Biegus J, Termaaten J, Ter Maaten J, et al.
J Card Fail
. 2025 Feb;
PMID: 39952388
During the past century, the characteristics of patients with heart failure (HF) and acute HF (AHF) have shifted from patients with severe pump failure due to rheumatic, hypertensive and ischemic...